ASAH2 deficiency affects sphingolipid homeostasis and neuromotor control, causing a progressive neurological disorder
Open Access
- 10 March 2026
- journal article
- Published by Elsevier in Human Genetics and Genomics Advances
- Vol. 7 (2) , 100587
Abstract
No abstract availableKeywords
Funding Information
- Compagnia di San Paolo (32628)
- Compagnia di San Paolo (PNRR-MUR-M4C2 PE0000006)
- Ministero della Salute (RF-2016-02361949)
- Warren Alpert Foundation
This publication has 30 references indexed in Scilit:
- Ceramides and their roles in programmed cell deathAdvances in Medical Sciences, 2023
- Very-long-chain fatty acids induce glial-derived sphingosine-1-phosphate synthesis, secretion, and neuroinflammationCell Metabolism, 2023
- DynaMut2: Assessing changes in stability and flexibility upon single and multiple point missense mutationsProtein Science, 2020
- ASAH1 pathogenic variants associated with acid ceramidase deficiency: Farber disease and spinal muscular atrophy with progressive myoclonic epilepsyHuman Mutation, 2020
- Characterization of intellectual disability and autism comorbidity through gene panel sequencingHuman Mutation, 2019
- The Role of Ceramide and Sphingosine-1-Phosphate in Alzheimer’s Disease and Other Neurodegenerative DisordersMolecular Neurobiology, 2019
- A novel pathogenic MYH3 mutation in a child with Sheldon–Hall syndrome and vertebral fusionsAmerican Journal of Medical Genetics Part A, 2018
- It’s a Lipid’s World: Bioactive Lipid Metabolism and Signaling in Neural Stem Cell DifferentiationNeurochemical Research, 2012
- Analysis of membrane topology of neutral sphingomyelinase 2FEBS Letters, 2007
- A novel gene derived from a segmental duplication shows perturbed expression in Alzheimer’s diseaseneurogenetics, 2007